Systemic therapy for cervical cancer with potentially regulatable oncolytic adenoviruses.
Clinical trials have confirmed the safety of selectively oncolytic adenoviruses for treatment of advanced cancers. However, increasingly effective viruses could result in more toxicity and therefore it would be useful if replication could be abrogated if necessary. We analyzed viruses containing the...
Guardado en:
Autores principales: | Anna Kanerva, Sergio Lavilla-Alonso, Mari Raki, Lotta Kangasniemi, Gerd J Bauerschmitz, Koichi Takayama, Ari Ristimäki, Renee A Desmond, Akseli Hemminki |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7fb6106d4cef4be68550981943378884 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Defects in innate immunity render breast cancer initiating cells permissive to oncolytic adenovirus.
por: Laura Ahtiainen, et al.
Publicado: (2010) -
SPECT/CT imaging of hNIS-expression after intravenous delivery of an oncolytic adenovirus and 131I.
por: Maria Rajecki, et al.
Publicado: (2012) -
Anti-tumor activity of a miR-199-dependent oncolytic adenovirus.
por: Elisa Callegari, et al.
Publicado: (2013) -
Mutation of the fiber shaft heparan sulphate binding site of a 5/3 chimeric adenovirus reduces liver tropism.
por: Anniina Koski, et al.
Publicado: (2013) -
Calcium gluconate in phosphate buffered saline increases gene delivery with adenovirus type 5.
por: Marko T Ahonen, et al.
Publicado: (2010)